Amarin (NASDAQ:AMRN – Get Free Report) is set to release its earnings data before the market opens on Wednesday, May 1st. Analysts expect Amarin to post earnings of ($0.04) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Amarin (NASDAQ:AMRN – Get Free Report) last issued its quarterly earnings results on Thursday, February 29th. The biopharmaceutical company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.04. The company had revenue of $74.71 million during the quarter, compared to the consensus estimate of $72.46 million. Amarin had a negative net margin of 19.26% and a negative return on equity of 10.47%. On average, analysts expect Amarin to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Amarin Trading Up 2.0 %
NASDAQ AMRN opened at $0.88 on Wednesday. The firm has a market capitalization of $362.74 million, a price-to-earnings ratio of -6.31 and a beta of 1.98. Amarin has a 1 year low of $0.65 and a 1 year high of $1.49. The firm’s 50 day simple moving average is $0.99 and its 200 day simple moving average is $0.93.
Analyst Upgrades and Downgrades
View Our Latest Research Report on Amarin
Amarin Company Profile
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
Featured Articles
- Five stocks we like better than Amarin
- What Are Dividend Achievers? An Introduction
- Charles Schwab Fortifies its Uptrend on EPS Beat
- The How And Why of Investing in Oil Stocks
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Manufacturing Stocks Investing
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Amarin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarin and related companies with MarketBeat.com's FREE daily email newsletter.